clinical trials semaglutide alzheimer's trial evoke and evoke+: design of two large-scale, double-blind, placebo Semaglutide Improves Weight Loss in

Su composicin contribuye al transporte de cidos grasos hacia las clulas, favoreciendo su utilizacin como fuente de energa durante la actividad fsica

Future studies would benefit from incorporating additional behavioral paradigms such as the Novel Object Recognition Test to assess recognition memory, the Y-maze to evaluate working memory, or the Barnes maze as an alternative assessment of spatial learning

Informed consent For this type of study, consent is not required

These figures represent least-squares mean percentage changes from baseline body weight, and the results in the higher-dose groups were statistically significant compared with placebo